NephroGenex Inc (NASDAQ:NRX)

7.87
Delayed Data
As of 2:07pm ET
 -0.39 / -4.72%
Today’s Change
3.96
Today|||52-Week Range
17.98
-41.05%
Year-to-Date
No recent news for NephroGenex Inc.

Today’s Trading

Previous close8.26
Today’s open8.20
Day’s range7.75 - 8.32
Volume30,339
Average volume (3 months)65,105
Market cap$73.2M
Dividend yield--
Data as of 2:07pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)+89.09%
Earnings growth (this year)-2.79%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.79

Competitors

 Today’s
change
Today’s
% change
CBAYCymaBay Therapeutics...-0.16-3.43%
DITAMCON Distributing C...+0.53+0.65%
MCPIEMed Cannabis Pharma ...-0.00-0.35%
BIOSBioScrip Inc-0.08-1.43%
Data as of 2:27pm ET, 04/27/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$0.00
Annual profit (last year)-$16.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Pierre Legault
President, Chief Scientific Officer &
Director
J. Wesley Fox Ahmann
Corporate headquarters
Durham, North Carolina

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers